News and Announcements
Yahoo Finance features Mad Paws as one of Australia’s up-and-coming startups in the pet industry
- Published October 13, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Yahoo Finance reports that consumers are spending $12.2 billion on the Australian pet industry annually.
Yahoo Finance’ recently zoomed in on the startups that are making waves in the pet market. Among these companies was Australia’s largest service platform, Mad Paws.
Mad Paws is Australia’s largest Pet Sitting marketplace that connects Pet Owners with 15,000 local, vetted, and insured Pet Sitters and Dog Walkers.
Last year, the company announced a massive win when a partnership was formed with their existing investor, Qantas.
Their successes continue to roll in with their current investment round now being 100% filled, and the company confirming to have space for more.
About Mad Paws:
Mad Paws has scaled rapidly across Australia and is a proud partner of Qantas, who is also an investor alongside Equity Venture Partners and Macdoch Ventures.
With an awesome team, Mad Paws recently ranked #14 on LinkedIn’s Top 25 Australian Startups to work for 2018.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
